InvestSMART

Singular Health Group Ltd (ASX:SHG)

ALERT: Price-sensitive ASX Announcement for SHG
Current share price for SHG : $0.210 -0.045 (-17.65%)+
Announcement
Release
27 Jan 2026 9:01AM
Price at Release
$0.255
Full Release
download
Summary
Singular Health Group Ltd made significant progress in the December quarter by advancing key initiatives in the U.S. and international markets. They scaled up commercial deployments, deepened partnerships, and expanded regulatory and technical capabilities. The company focused on delivering interoperable imaging solutions, achieving milestones such as deploying 250 licenses of 3DICOM MD® to PNS's network and transitioning Life Radiology's pilot program to full patient deployment. Additionally, Singular Health strengthened its commercial position through strategic partnerships and pursued new contracts, including a multi-million-dollar project request to the U.S. House of Representatives. They released updates to enhance their 3DICOM™ Mobile app and pursued regulatory milestones, including submitting a 510(k) application to the FDA. Investor relations were also advanced through presentations at major conferences, highlighting the company's market potential and strategic direction.
Key Points
  • Singular Health progressed key initiatives in U.S. and international markets.
  • 250 licenses of 3DICOM MD® successfully deployed to PNS's network.
  • Life Radiology's pilot program transitioned to full patient deployment.
  • Strategic partnerships and new contracts pursued, including a project request to the U.S. House of Representatives.
  • 3DICOM™ Mobile app updates introduced for improved usability.
  • 510(k) application submitted to the FDA for regulatory clearance.
  • Presentations at major conferences reinforced Singular Health's market position.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.